Lexicon Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Lexicon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Lexicon Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexicon Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $87k | 55k | 1.57 |
| 2024-06-30 | $93k | 55k | 1.68 |
| 2023-09-30 | $47k | 43k | 1.09 |
| 2023-06-30 | $98k | 43k | 2.29 |
| 2023-03-31 | $104k | 43k | 2.43 |
| 2022-12-31 | $42k | 22k | 1.91 |
| 2022-09-30 | $96k | 40k | 2.40 |
| 2021-12-31 | $101k | 26k | 3.94 |
| 2021-09-30 | $123k | 26k | 4.81 |
| 2019-06-30 | $150k | 24k | 6.29 |
| 2019-03-31 | $133k | 24k | 5.56 |
| 2018-12-31 | $158k | 24k | 6.64 |
| 2018-09-30 | $381k | 36k | 10.67 |
| 2018-06-30 | $286k | 24k | 12.00 |
| 2018-03-31 | $204k | 24k | 8.56 |
| 2017-12-31 | $236k | 24k | 9.90 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors